BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12130494)

  • 21. Retrovirus-mediated expression of the base excision repair proteins, formamidopyrimidine DNA glycosylase or human oxoguanine DNA glycosylase, protects hematopoietic cells from N,N',N"-triethylenethiophosphoramide (thioTEPA)-induced toxicity in vitro and in vivo.
    Kobune M; Xu Y; Baum C; Kelley MR; Williams DA
    Cancer Res; 2001 Jul; 61(13):5116-25. PubMed ID: 11431349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro evidence for homologous recombinational repair in resistance to melphalan.
    Wang ZM; Chen ZP; Xu ZY; Christodoulopoulos G; Bello V; Mohr G; Aloyz R; Panasci LC
    J Natl Cancer Inst; 2001 Oct; 93(19):1473-8. PubMed ID: 11584063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human CD34+ hematopoietic progenitor cells are sensitive targets for toxicity induced by 1,4-benzoquinone.
    Abernethy DJ; Kleymenova EV; Rose J; Recio L; Faiola B
    Toxicol Sci; 2004 May; 79(1):82-9. PubMed ID: 14976336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study.
    de la Rubia J; Bladé J; Lahuerta JJ; Ribera JM; Martínez R; Alegre A; García-Laraña J; Fernández P; Sureda A; de Arriba F; Carrera D; Besalduch J; García Boyero R; Palomera Bernal L; Hernández MT; García PR; Pérez-Calvo J; Alcalá A; Casado LF; San Miguel J
    Haematologica; 2006 May; 91(5):621-7. PubMed ID: 16627253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential gene expression underlying the functional distinctions of primary human CD34+ hematopoietic stem and progenitor cells from peripheral blood and bone marrow.
    Steidl U; Kronenwett R; Haas R
    Ann N Y Acad Sci; 2003 May; 996():89-100. PubMed ID: 12799287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hematopoietic stem/progenitor cells are less prone to undergo apoptosis than lymphocytes despite similar DNA damage response.
    Durdik M; Kosik P; Kruzliakova J; Jakl L; Markova E; Belyaev I
    Oncotarget; 2017 Jul; 8(30):48846-48853. PubMed ID: 28415626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased DNA single-strand break joining activity in UV-irradiated CD34+ versus CD34- bone marrow cells.
    Myllyperkiö MH; Vilpo JA
    Mutat Res; 1999 Mar; 425(1):169-76. PubMed ID: 10082927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 elevation in relation to levels and cytotoxicity of mono- and bifunctional melphalan-DNA adducts.
    Gould KA; Nixon C; Tilby MJ
    Mol Pharmacol; 2004 Nov; 66(5):1301-9. PubMed ID: 15308759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical detection of melphalan-DNA adducts in colon cancer cells in vitro and human colorectal liver tumours in vivo.
    Rothbarth J; Koevoets C; Tollenaar RA; Tilby MJ; van de Velde CJ; Mulder GJ; Kuppen PJ
    Biochem Pharmacol; 2004 May; 67(9):1771-8. PubMed ID: 15081876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of resistance to a trinuclear platinum complex in ovarian carcinoma cells.
    Perego P; Gatti L; Righetti SC; Beretta GL; Carenini N; Corna E; Dal Bo L; Tinelli S; Colangelo D; Leone R; Apostoli P; Lombardi L; Beggiolin G; Piazzoni L; Zunino F
    Int J Cancer; 2003 Jul; 105(5):617-24. PubMed ID: 12740909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypersensitivity to DNA cross-linking agents associated with up-regulation of glucose-regulated stress protein GRP78.
    Chatterjee S; Hirota H; Belfi CA; Berger SJ; Berger NA
    Cancer Res; 1997 Nov; 57(22):5112-6. PubMed ID: 9371511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA damage and repair in peripheral blood lymphocytes from healthy individuals and cancer patients: a pilot study on the implications in the clinical response to chemotherapy.
    Nadin SB; Vargas-Roig LM; Drago G; Ibarra J; Ciocca DR
    Cancer Lett; 2006 Jul; 239(1):84-97. PubMed ID: 16143448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fludarabine-mediated repair inhibition of cisplatin-induced DNA lesions in human chronic myelogenous leukemia-blast crisis K562 cells: induction of synergistic cytotoxicity independent of reversal of apoptosis resistance.
    Li L; Keating MJ; Plunkett W; Yang LY
    Mol Pharmacol; 1997 Nov; 52(5):798-806. PubMed ID: 9351970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human umbilical cord blood hematopoietic progenitor cells: are they the same as their adult bone marrow counterparts?
    Traycoff CM; Abboud MR; Laver J; Clapp DW; Hoffman R; Law P; Srour EF
    Blood Cells; 1994; 20(2-3):382-90; discussion 390-1. PubMed ID: 7538343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
    Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
    Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection and quantification of melphalan-DNA adducts at the single cell level in hematopoietic tumor cells.
    Frank AJ; Proctor SJ; Tilby MJ
    Blood; 1996 Aug; 88(3):977-84. PubMed ID: 8704257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti-cancer agents.
    Damia G; Imperatori L; Stefanini M; D'Incalci M
    Int J Cancer; 1996 Jun; 66(6):779-83. PubMed ID: 8647649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of interleukin-1beta-converting enzyme in human hematopoietic progenitor cells results in blockade of cytokine-mediated apoptosis and expansion of their proliferative potential.
    Sloand EM; Young NS; Sato T; Kim S; Maciejewski JP
    Exp Hematol; 1998 Oct; 26(11):1093-9. PubMed ID: 9766451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of DNA damage induced by aflatoxin B1 in hepatocyte-like cells, their progenitor mesenchymal stem cells and CD34(+) cells isolated from umbilical cord blood.
    Ghaderi M; Allameh A; Soleimani M; Rastegar H; Ahmadi-Ashtiani HR
    Mutat Res; 2011 Feb; 719(1-2):14-20. PubMed ID: 20883820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA-PKcs, a novel functional target of acriflavine, mediates acriflavine's p53-dependent synergistic anti-tumor efficiency with melphalan.
    Cao J; Lin G; Gong Y; Pan P; Ma Y; Huang P; Ying M; Hou T; He Q; Yang B
    Cancer Lett; 2016 Dec; 383(1):115-124. PubMed ID: 27693638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.